Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
Rohina Joshi(UNSW Sydney), Laurent Billot(The George Institute for Global Health), Anthony Rodgers(The George Institute for Global Health), Bryan Williams(The London College), Pavel Hamet(Centre Hospitalier de l’Université de Montréal), Stephen MacMahon, Mark Woodward(UNSW Sydney), Séverine Bompoint(Royal North Shore Hospital), Stephen Harrap(The Royal Melbourne Hospital), Simon Heller(University of Sheffield), John Chalmers(UNSW Sydney), Mark E. Cooper(Australian Regenerative Medicine Institute), Bastiaan E. de Galan(Université Paris Cité), Neil R Poulter(Imperial College London), Bruce Neal(UNSW Sydney), Anushka Patel(UNSW Sydney), Michel Marre(Centre National de la Recherche Scientifique), Lisheng Liu(Aarhus University), Changyu Pan(University of Auckland), Giuseppe Mancia(Chinese General Hospital College of Nursing and Liberal Arts), Diederick E. Grobbee(University Medical Center Utrecht), Paul Glasziou(Bond University), C. E. Mogensen(St Mary's Hospital)
Cited by 7,406
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k